Consilium Wealth Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Sell |
2,000
-112
| -5% | -$20.8K | 0.16% | 75 |
|
|
2025
Q1 | $442K | Sell |
2,112
-3,163
| -60% | -$663K | 0.22% | 67 |
|
|
2024
Q4 | $937K | Sell |
5,275
-2,126
| -29% | -$378K | 0.45% | 41 |
|
|
2024
Q3 | $1.46M | Buy |
7,401
+5,401
| +270% | +$1.07M | 0.8% | 27 |
|
|
2024
Q2 | $343K | Hold |
2,000
| – | – | 0.19% | 66 |
|
|
2024
Q1 | $364K | Sell |
2,000
-1,261
| -39% | -$230K | 0.2% | 66 |
|
|
2023
Q4 | $505K | Sell |
3,261
-4,209
| -56% | -$652K | 0.3% | 57 |
|
|
2023
Q3 | $1.11M | Buy |
7,470
+2,854
| +62% | +$425K | 0.78% | 27 |
|
|
2023
Q2 | $622K | Buy |
4,616
+1,174
| +34% | +$158K | 0.43% | 47 |
|
|
2023
Q1 | $549K | Sell |
3,442
-377
| -10% | -$60.1K | 0.47% | 45 |
|
|
2022
Q4 | $617K | Buy |
3,819
+498
| +15% | +$80.5K | 0.53% | 44 |
|
|
2022
Q3 | $446K | Buy |
3,321
+1,315
| +66% | +$177K | 0.5% | 48 |
|
|
2022
Q2 | $307K | Sell |
2,006
-220
| -10% | -$33.7K | 0.33% | 61 |
|
|
2022
Q1 | $361K | Buy |
2,226
+226
| +11% | +$36.7K | 0.26% | 65 |
|
|
2021
Q4 | $271K | Buy |
+2,000
| New | +$271K | 0.18% | 78 |
|